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1 |  INTRODUCTION
Neck lymph node (LN) metastasis is common in patients with 
oral cancer (OC), but occipital LN metastasis in OC patients 
has not yet been reported. In this case report, we describe an 
OC patient with delayed metastasis to the occipital LN in the 
ipsilateral side.
Treatment and control of regional lymph node (LN) me-
tastasis are an important prognostic factor in oral cancer 
(OC). The incidence of neck LN metastases in OC is 20%-
30%.1-5 In addition, the chance of developing a neck LN 
metastasis after initial treatment of OC varies from 12.4% 
to 62%.6,7 The prognosis is poor in patients with neck LN 
metastasis of OC, and the survival rate varies depending on 
the degree of metastasis. The appearance of metastases to 
the neck LNs subtly differs depending on the subsite of pri-
mary lesion in OC, but most are often found in the neck LNs 
including the submandibular and the superior internal jugular 
region. However, to our knowledge, metastasis to the occip-
ital LN in OC is very rare and has not been reported to date. 
In this paper, we report a case of OC with delayed metastasis 
to occipital LN in the ipsilateral side after neck dissection.
2 |  CASE REPORT
A 62-year-old woman was referred by her dentist to our 
department in May 2013 with a suspected malignancy of 
the right tongue. The patient did not complain of pain, but 
uncomfortable stiffness of the tongue. She had no history 
of trauma, disease, surgery, or smoking, and only a small 
amount of daily drinking. Physical examination showed an 
ulcerative lesion measuring 14 × 10 mm with induration was 
recognized on the right lateral edge of the posterior tongue 
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Consideration of unexpected metastasis in patients who have undergone neck dissec-
tion with advanced tumors must be anticipated with careful follow-up.
K E Y W O R D S
delayed metastasis, lymphatic regurgitation, neck dissection, occipital lymph node, oral cancer
2 |   ONO et al.
at the first visit (Figure 1). The submandibular LNs of 8 mm 
diameter were palpable, mobile, and not tender. The results 
of cytology of the lesion in the oral cavity showed Class 
IV. Ultrasonography showed the presence of a tumor with 
a thickness of about 8  mm inward at the lesion site. Head 
and neck contrast-enhanced computed tomography (CE-CT) 
imaging strengthened the clinical suspicion of an OC of the 
right lateral edge of the tongue. Magnetic resonance (MR) 
imaging revealed the primary tumor extended into the right 
tongue region, inward with thickness of 10 mm or more, and 
LNs enlarged at the right superior internal jugular region 
(Figure 2A-C). Correspondingly, positron emission tomogra-
phy (PET)-CT showed abnormal accumulation of FDG in the 
right lateral edge of the tongue (SUVmax = 6.98) and LNs at 
the right superior internal jugular region (SUVmax = 3.27), 
and no abnormal accumulation of FDG in other organs 
(Figure  2D). As a part of the staging and planning proce-
dures, biopsy was performed, and the result was confirmed to 
be squamous cell carcinoma (SCC). Accordingly, the patient 
was clinically diagnosed with T2N1M0 stage III in the TNM 
classification of the 7th edition at that time.
In June 2013, we performed partial tongue resection in-
cluding tumor lesion and modified radical neck dissection 
(type III; preserving sternocleidomastoid muscle, internal 
jugular vein, and accessory nerves) at the right side. The his-
topathological examination of the resected tongue specimen 
showed a predominantly moderately differentiated SCC with 
some poorly differentiated regions (Figure 3A, B) and find-
ings of vascular invasion of tumor cells (Figure 3C), and the 
resected neck LNs specimen showed only one nodal metas-
tasis at level IIa LN (pT2 pN1 (1/50) Ly1 V1 Pn0 G2 > G3, 
local R0). Interestingly, many cell divisions were observed in 
both resected specimens depending on the site, which were 
16 per 10 high-power field (HPF) of primary tumor lesion 
and 13 per 10 HPF of neck LN metastatic lesion (Figure 3D, 
E). Complete tumor disappearance resulted from surgery, 
and we decided that no additional treatment was needed as 
histology confirmed that there were negative resection speci-
men margin and no extranodal extension (ENE).
However, at the time of follow-up in September 2013, 
a subcutaneous mass enlargement of the right posterior 
neck on the ipsilateral side was observed (Figure  4A). 
Ultrasonography revealed a 10 mm bulge near the trapezius 
muscle on the right posterior neck. Furthermore, CT imaging 
showed that the occipital LN had a tendency of rapid swell-
ing and contrast enhancing compared with which was taken 
a month ago (Figure 4B). Correspondingly, PET-CT showed 
abnormal accumulation of FDG (SUVmax = 7.58) in the ip-
silateral posterior neck (Figure 4C). As a side note, physical 
examination and these image examinations did not find local 
recurrence of the tongue or metastasis to the contralateral 
neck LN.
Suspected delayed LN metastasis was considered and 
lymphadenectomy was performed for the purpose of patho-
logical examination. The histopathological examination 
of the resected specimen showed presence of proliferating 
tumor cells, forming tumor nests. Tumor tissue was moder-
ately differentiated SCC, accompanied by many cell divisions 
(11 per 10 HPF), and the LN-specific structure disappeared 
(Figure 5). Based on the findings above, we considered that 
additional treatment was necessary, and the patient was 
treated with bioradiation (BRT), cetuximab (initial dose of 
400 mg/m2 with subsequent weekly doses of 250 mg/m2 in-
travenously, total 8 courses) combination radiotherapy (2 Gy/
day, total dose of 60  Gy). Subsequentially, we have been 
conducting regular follow-up, but thus far it has been 7 years 
with no sign of local recurrence, other LNs metastasis, and 
distant metastasis.
3 |  DISCUSSION
Oral cancer is an aggressive disease that mainly metastasizes 
to neck LNs. The extent of neck area invasion directly affects 
the prognosis of the patient, regardless of the number, the size 
of metastatic LNs, and the presence of ENE.8 Akhter M et al9 
found that the prognosis of OC patients with neck LN metas-
tasis was worse than those of without LN metastasis, and me-
tastases to the LN nodes were more likely to develop distant 
metastases. The most common pattern of neck LN metastasis 
of OC is level I or II LNs.10,11 On the other hand, the rate of 
metastasis to level V LNs was low, and Lim et al showed 
only 5% (5 of 93) of OC and oropharyngeal cancer with clini-
cally N positive (cN+) had positive of level V LNs, and all 
of which cases also had positive of other level LNs.12 Parikh 
et al also reported that 0% (0 of 99) of cN1 with palpable 
level Ib LNs, 8% (1 of 13) of cN1 with palpable level II/ 
III LNs, and 16% (8 of 49) of cN2 were positive of level V 
LNs.13 In addition, there are many cases in which latent me-
tastases are found in cN0 cases with no clinically recognized 
F I G U R E  1  Intra-oral findings at first physical examination. A 
tumor was located on the right lateral edge of the tongue
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LN metastasis. Li et al14 and Parikh et al13 reported that about 
20% of cN0 had potentially latent LN metastasis. However, 
all of them were negative of level V LNs. Incidentally, stud-
ies of LN metastasis in the head and neck region, including 
oral cavity, did not reveal a lymphatic drainage route to the 
occipital LNs.
Occipital LNs are located at level Xb LN in “the guide-
lines of the lymph node levels modified from Robbins.15” 
The occipital LNs are located at the junction of the calvaria 
and the apex, and divided into three places, such as (a) su-
prafascial/superficial, (b) subfascial and (c) submuscular/ 
subsplenius, from the surface layer to the deep part accord-
ing to the anatomical relationship with the fascia and mus-
cle. The import lymph vessels of the occipital LN include 
the scalp of the occipital region, the skin of the apex, the 
deep layer of the occipital neck, and the export lymph ves-
sels which mainly flow into the upper part of the accessory 
nerve LNs.16 Maeda et al reported that 67% (4 of 6) of the 
occipital skin cancers spreading to the occipital LNs showed 
metastasis to level V LNs,17 and this result supported that the 
efferent lymphatic vessels of the occipital LNs are accessory 
nerve LNs. Furthermore, it is known that a part of occipital 
lymph vessels also drains into the jugulodigastric LN located 
in neck node level IIa.18 The jugulodigastric LNs form part of 
the upper internal jugular LNs located in the carotid trigone. 
Especially in the head and neck region, tumors of the base 
of the tongue, the pharynx, and the tonsils are often metasta-
sized to jugulodigastric LNs.19
Lymph node metastasis shows a metastatic pattern along 
the lymph flow from the primary lesion, and the level at which 
metastasis frequently occurs has been clarified depending on 
the primary site. Therefore, preservation of LN groups with 
a rare metastasis frequency does not impair treatment re-
sults. Accordingly, neck dissection is performed in advanced 
cases, but antegrade lymphatic flow may be blocked by neck 
dissection itself or obstruction of adjacent lymph vessels 
associated with tumor progression. As a result, lymphatic 
regurgitation may occur, and residual tumor cells may un-
expectedly disseminate by a route that ignores the original 
lymphatic flow.20-22 Yang et al hypothesized that extensive 
neck LN metastasis, particularly meeting the condition of N3, 
was a risk factor for lymphatic regurgitation to the occipital 
LN metastasis.23 However, in the case we experienced, the 
pathological results of the LNs dissected in the initial sur-
gery showed metastasis was found only in level IIa LN, but 
delayed metastasis to the occipital LN was found at 3 months 
postsurgery. Li et al showed that extensive obstruction of in-
ternal jugular vein nodes caused by neck LN metastasis of 
nasopharyngeal cancer may occur lymphatic regurgitation to 
occipital LN24. In this case, we cannot determine the cause of 
occipital LN metastasis, but it was suggested that the follow-
ing two points may be involved: (a) changes in lymph flow 
F I G U R E  2  A, B: Axial (A) and 
coronal (B) fat-suppressed T2-weighted MR 
image showing the primary tumor (arrow) 
with inward extension on the right lateral 
edge of the tongue. Scale bar: 10 mm. C: 
Coronal fat-suppressed T2-weighted MR 
image showing swelling of LN (arrowhead) 
in the right superior internal jugular 
region. Scale bar: 10 mm. D: PET-CT 
showing abnormal accumulation of FDG 
at the right superior internal jugular region 
(SUVmax = 3.27)
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due to neck dissection and (b) obstruction of internal jugular 
LNs due to tumor progression.
For LN metastasis, it is important to confirm lymphade-
nopathy, induration, and mobility by palpation. Besides that, 
imaging test is often useful for diagnosing metastatic LNs, 
and occipital LN metastases are visualized as a superficial 
mass located at the cranial and superficial of posterior neck.25 
CT may confirm metastases regardless of size if central 
F I G U R E  3  Hematoxylin and eosin staining showing pathological features of resected specimen at initial surgery. Scale bar: 50 μm. A, B: The 
primary tumor had predominantly moderately differentiated regions (A) with some poorly differentiated regions (B). C: Vascular invasion findings 
of tumor cells (arrow head) at primary tumor. D, E: Cell division findings of tumor cells (arrow heads) at primary tumor lesion (D) and neck LN 
metastatic lesion (E)
F I G U R E  4  A: Right posterior neck findings at 3 mo after initial surgery. A subcutaneous mass enlargement was palpable. B: CE-CT image 
showing a swelling of the right occipital LN (arrow head) suspected of metastasis. CT images 2 (left) and 3 mo (right) after initial surgery. C: PET-
CT showing abnormal accumulation of FDG at the right occipital region (SUVmax = 7.58)
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necrosis is present. CE-CT shows LN central necrosis as a 
central area of low attenuation surrounded by an irregular 
rim-enhancing tissue.26,27 On the other hand, pathologically, 
the LN structure may have already been impacted at the time 
when the metastasis was clinically revealed as in this case; 
thus, it was difficult to prove whether it was true LN metas-
tasis. However, in this case, we considered the delayed tumor 
was occipital LN metastasis from the primary tongue tumor 
by the following reasons: Tumor was found in the position of 
occipital LN by CE-CT early postoperation, the histological 
type was moderately differentiated SCC with many cell divi-
sions consistent with the primary tumor, and a whole-body 
search using PET-CT revealed no malignant tumor in another 
organs.
The TNM classification is the international standard 
for the progression of malignant tumors advocated by the 
American Joint Committee of Cancer (AJCC) and the Union 
for International Cancer Control (UICC). Although the defi-
nition of T classification (T1 to T3) of OC had not been 
revised for almost 30  years, the concept of depth of inva-
sion (DOI) of the primary lesion was added in the revised 
8th edition of the AJCC/UICC staging system published in 
2017. Specifically, in addition to the concept of the maxi-
mum tumor diameter of the 7th edition, the T classification 
of the 8th edition added the criteria of being classified as T2 
or more when the DOI exceeds 5 mm and T3 when the DOI 
exceeds 10 mm. We initially diagnosed T2N1M0 based on 
the size of the primary tumor and the presence or absence of 
neck LN metastasis. However, according to the classification 
of the 8th edition, it should be classified as T3 because the 
tumor depth of ≥10 mm was recognized on the MR image 
(Figure 2). There have been reports that tumor depth is a risk 
factor for delayed neck LN metastasis.28,29 The International 
Consortium for Outcome Research (ICOR) in Head and Neck 
Cancer conducted an international large-scale retrospective 
study of 3149 OC cases in 22 years at 11 centers. As a re-
sult, it was proved that the DOI was a more important factor 
in poor prognosis rather than the size of the tumor itself.30 
In our case as well, the depth of the tumor, which was not 
evaluated at that time, may have led to a poor postoperative 
outcome.
Metastasis to the occipital LNs is very rare in the first place 
and can occasionally occur in cases such as malignant tumors 
of the occipital skin and skin appendages, malignant tumors of 
the ear canal, and melanoma of the head and neck. Other rare 
cases of occipital LN metastasis have been reported in sweat 
gland tumors,31 lung cancer,32 and thyroid cancer.33,34 In head 
and neck cancer, it was reported that there was no risk of me-
tastasis to the occipital LNs, except in the case of skin,16 but as 
mentioned above, there are reports of metastasis to the occipital 
LNs in nasopharyngeal cancer.23,24 To our knowledge, our case 
is the first report of occipital LN metastasis arising from oral 
cavity. Various treatments have been applied to occipital LN 
metastases of each cancer type. Lin et al33 performed dissec-
tion of the occipital LN with resection of the primary lesion 
in a case of papillary thyroid cancer. No further treatment was 
given, and the patient died 17 months later due to brain metas-
tases. Sheth et al31 performed radiation therapy as an additional 
treatment after the surgery in a case of eccrine mucinous cancer 
and achieved disease-free survival of 4 years. After that, recur-
rence and metastasis were repeatedly observed, but a long-term 
survival course was achieved by performing tumor resection 
and radiotherapy each time. Yang et al23 performed chemora-
diation therapy combined with cisplatin and 5-fluorouracil as 
an additional treatment after tumor resection in a cases of na-
sopharyngeal cancer. After that, distant metastases were found 
in the sternum, left iliac, bilateral breast LNs, and spleen, but a 
long-term survival course was achieved without any recurrence 
in the primary region and related areas. Normally, in head and 
neck cancer, metastases are rarely found in the LNs of occipital, 
parotid, and facial, which are outside of the normal dissection 
area. Furthermore, metastases in these areas have been reported 
to have a poorer prognosis than metastases to neck LNs (level 
I–V) within the dissection area.35-37 We performed BRT com-
bined with cetuximab as an additional treatment after excision 
of metastatic LN and achieved good progress with a survival 
time of 7 years or more. Although there are some risks of re-
currence and/or distant metastasis, these cases mentioned above 
including our case suggest that comprehensive methods and 
multidisciplinary management including surgery, chemother-
apy, and radiation therapy used for common cancer metastases 
may be important even to unexpected metastasis.
F I G U R E  5  Hematoxylin and eosin 
staining showing pathological features of 
resected occipital LN. Scale bar: 50 μm. 
(A) The delayed tumor had predominantly 
moderately differentiated lesion. (B) Cell 
division findings of tumor cells (arrow 
heads) at delayed tumor lesion
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4 |  CONCLUSION
Metastasis to regional LNs for OC, such as occipital LN, is 
very rare, but we should consider the changes of lymph flow 
in the patients who underwent neck dissection with advanced 
tumors, and follow up them consistently and carefully.
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